Safety of an Accelerated Build-up Phase With Pollen Allergoids: A Retrospective Study

J Investig Allergol Clin Immunol. 2018 Aug;28(4):283-284. doi: 10.18176/jiaci.0269.

¹ Allergy Unit - Fondazione Policlinico Gemelli -Presidio Columbus, Rome, Italy.
² Allergy and Clinical Immunology Department, ASST Fatebenefratelli Sacco, Milan, Italy.
³ Clinical Allergy and Immunology Unit, Legnano Hospital, Legnano, Italy.
⁴ Allergy Outpatient Clinic, AUSL Reggio Emilia, Reggio Emilia, Italy.
⁵ Clinical Medicine Department and Molecular Medicine Department, Sapienza University, Rome, Italy.
⁶ Clinical Allergy and Immunology Unit, Foundation IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
⁷ Clinical Allergy and Immunology Unit, AUSL Parma, Parma, Italy.
⁸ Allergology and Immunology Unit, Novara Hospital, Novara, Italy.

No abstract available

Keywords: Accelerated dose escalation; Allergoid; Safety; Subcutaneous immunotherapy; Tolerability.

MeSH terms